South & Central America Opioids Market Forecast to 2030 - Regional Analysis - by Product (Immediate Release Short Acting Opioid and Extended Release Long Acting Opioid), Application (Pain Management, Anesthesia, Diarrhea Suppression, Cough Suppression, De-Addiction, and Others), Route of Administration (Oral, Injectable, and Transdermal Patch), and Distribution Channel (Hospital Pharmacies and Retail Pharmacies)
Increasing Geriatric Population Fuel South & Central America Opioids Market
The majority of older people live with chronic pain, resulting in reduced strength to carry out their daily routine. The geriatric population widely suffers from bone and joint disorders, arthritis, cancer, and other chronic disorders causing pain. According to the World Health Organization (WHO) data from February 2018, the geriatric population is estimated to grow by 22% by 2050 compared with 12% in 2015. The data also stated that low- and middle-income countries would account for nearly 80% of this surge. A number of developed countries are also experiencing significant growth in the geriatric population, which is driven by improved healthcare facilities and better healthcare services; this has resulted in increased life expectancy in these regions. An aging population drives the opioid market primarily through increased demand for pain management solutions. Additionally, older adults often undergo surgeries and medical procedures that necessitate pain management. Thus, the growing geriatric population across the region drives the growth of the opioids market.
South & Central America Opioids Market Overview
According to the data from the Pan American Health Organization (PAHO), more than 30 million people in Brazil are aged 60 and above, representing 13% of the country's population. By 2030, this count is expected to reach ~50 million, representing 24% of the Brazilian population. As per the Brazilian Institute of Geography and Statistics, the country's population aged 65 and above is expected to hold a 36% share of the total population of Brazil by 2050. Chronic pain is one of the most common conditions affecting older adults. People suffering from this condition prefer using opioid products, leading to increased opioid prescriptions.
According to The Brazilian Health Regulatory Agency (ANVISA) and Brazilian private hospital systems Brazil was severely affected by the onset of the COVID-19 pandemic, with 700,000 deaths as of April 2022. The health conditions of its citizens were worsened by delays in vaccine availability, leading to high rates of hospitalization and ventilation for severe cases that accelerated the demand for fentanyl, used as a sedative during intubation, according to The Brazilian Health Regulatory Agency (ANVISA) and Brazilian private hospital systems.
Further, according to data published in The Lancet Regional Health-Americas in April 2023, there has been an increase in prescription opioid use in Brazil in the past two decades, including for medical and non-medical purposes, which is driving the market in Brazil.
South & Central America Opioids Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Opioids Market Segmentation
The South & Central America opioids market is categorized into product, application, route of administration, distribution channel, and country.
Based on product, the South & Central America opioids market is segmented immediate release short acting opioid and extended release long acting opioid. The immediate release short acting opioid segment held a larger market share in 2022. The immediate release short acting opioid is further sub segmented into oxycodone, hydrocodone, tramadol, codine, propoxyphene, and others. The extended release long acting opioid is further sub segmented into oxycodone, fentanyl, morphine, methadone, and others.
In terms of application, the South & Central America opioids market is categorized into pain management, anesthesia, diarrhea suppression, cough suppression, de-addiction, and others. The pain management segment held the largest market share in 2022.
By route of administration, the South & Central America opioids market is segmented into oral, injectable, and transdermal patch. The oral segment held the largest market share in 2022.
By distribution channel, the South & Central America opioids market is bifurcated into hospital pharmacies and retail pharmacies. The hospital pharmacies segment held a larger market share in 2022.
By country, the South & Central America opioids market is segmented into Brazil, Argentina, and the Rest of LATUM. Brazil dominated the South & Central America opioids market share in 2022.
Endo International plc, Mallinckrodt Plc, Neuraxpharm Pharmaceuticals SL, Rusan Pharma Ltd, and Teva Pharmaceutical Industries Ltd are some of the leading companies operating in the South & Central America opioids market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - South & Central America Analysis
5.1 South & Central America Opioids Market Revenue (US$ Million), 2020-2030
5.2 South & Central America Opioids Market Forecast Analysis
6. South & Central America Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. South & Central America Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Opioids Market - Country Analysis
10.1 South & Central America
10.1.1 South & Central America Opioids Market, by Key Countries - Revenue (2022) (US$ Million)
10.1.2 South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.2.1 South & Central America: Opioids Market - Revenue and Forecast Analysis - by Country
10.1.2.2 Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Brazil: South & Central America Opioids Market Breakdown, by Product
10.1.2.2.2 Brazil: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.2.3 Brazil: South & Central America Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.2.2.4 Brazil: South & Central America Opioids Market Breakdown, by Application
10.1.2.2.5 Brazil: South & Central America Opioids Market Breakdown, by Route of Administration
10.1.2.2.6 Brazil: South & Central America Opioids Market Breakdown, by Distribution Channel
10.1.2.3 Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Argentina: South & Central America Opioids Market Breakdown, by Product
10.1.2.3.2 Argentina: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.3.3 Argentina: South & Central America Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.2.3.4 Argentina: South & Central America Opioids Market Breakdown, by Application
10.1.2.3.5 Argentina: South & Central America Opioids Market Breakdown, by Route of Administration
10.1.2.3.6 Argentina: South & Central America Opioids Market Breakdown, by Distribution Channel
10.1.2.4 Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 Rest of South & Central America: Opioids Market Breakdown, by Product
10.1.2.4.2 Rest of South & Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.4.3 Rest of South & Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.2.4.4 Rest of South & Central America: Opioids Market Breakdown, by Application
10.1.2.4.5 Rest of South & Central America: Opioids Market Breakdown, by Route of Administration
10.1.2.4.6 Rest of South & Central America: Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Rusan Pharma Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. South & Central America Opioids Market Segmentation
Table 2. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 13. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. Recent Organic Growth Strategies in Opioids Market
Table 29. Recent Inorganic Growth Strategies in the Opioids Market
Table 30. Glossary of Terms, Opioids Market
List of Figures
Figure 1. South & Central America Opioids Market Segmentation, by Country
Figure 2. South & Central America Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. South & Central America Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. South & Central America Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. South & Central America Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 23. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Growth Strategies in Opioids Market
- Endo International plc
- Mallinckrodt Plc
- Neuraxpharm Pharmaceuticals SL
- Rusan Pharma Ltd
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America opioids market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America opioids market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America opioids market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.